# Evaluation of Thyroid Abnormity Incidence and Thyroid Toxicity During Chemotherapy Among Newly Diagnosed Breast Cancer

> **NCT03177902** · — · UNKNOWN · sponsor: **The First Affiliated Hospital of Bengbu Medical University** · enrollment: 400 (estimated)

## Conditions studied

- Breast Cancer Female
- Thyroid Gland

## Interventions

- **DRUG:** Chemotherapy

## Key facts

- **NCT ID:** NCT03177902
- **Lead sponsor:** The First Affiliated Hospital of Bengbu Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-06-04
- **Primary completion:** 2019-04
- **Final completion:** 2019-06
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2017-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03177902

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03177902, "Evaluation of Thyroid Abnormity Incidence and Thyroid Toxicity During Chemotherapy Among Newly Diagnosed Breast Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03177902. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*